All products / DC32961
CAT. NO. DC32961
PHA-543613
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $509 USDRequest a quote / confirm availability → |
| 250 mg | $1,018 USDRequest a quote / confirm availability → |
| 1g | $2,036 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
PHA-543613 acts as a potent and selective agonist for the α7 subtype of neural nicotinic acetylcholine receptors, with a high level of brain penetration and good oral bioavailability. It is under development as a possible treatment for cognitive deficits in schizophrenia.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC32961 |
|---|---|
| Product name | PHA-543613 |
| CAS | 478149-53-0 |
| Molecular formula | C15H18ClN3O2 |
| Molecular weight | 307.77500 |
| Purity | >98% |
| SMILES | Cl.O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — PHA-543613 (DC32961)